Conning Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.51M Sell
8,163
-581
-7% -$589K 0.25% 91
2025
Q4
$9.4M Sell
8,744
-1,525
-15% -$1.46M 0.31% 86
2025
Q3
$7.84M Sell
10,269
-160
-2% -$119K 0.26% 87
2025
Q2
$8.13M Buy
10,429
+1,033
+11% +$803K 0.28% 79
2025
Q1
$7.76M Sell
9,396
-1,219
-11% -$1.01M 0.27% 78
2024
Q4
$8.19M Buy
10,615
+411
+4% +$340K 0.29% 79
2024
Q3
$9.04M Sell
10,204
-370
-3% -$333K 0.3% 76
2024
Q2
$9.57M Sell
10,574
-878
-8% -$702K 0.34% 73
2024
Q1
$8.91M Sell
11,452
-890
-7% -$633K 0.29% 78
2023
Q4
$7.19M Sell
12,342
-84
-0.7% -$49K 0.25% 91
2023
Q3
$6.67M Sell
12,426
-1,671
-12% -$861K 0.24% 93
2023
Q2
$6.61M Buy
14,097
+7,902
+128% +$3.31M 0.22% 97
2023
Q1
$2.13M Sell
6,195
-97,570
-94% -$32.9M 0.07% 152
2022
Q4
$37.9M Sell
103,765
-14,027
-12% -$4.97M 1.23% 12
2022
Q3
$38.1M Sell
117,792
-29,045
-20% -$9.2M 1.35% 7
2022
Q2
$47.5M Sell
146,837
-34,146
-19% -$10.2M 1.42% 6
2022
Q1
$51.8M Sell
180,983
-19,297
-10% -$4.97M 1.41% 6
2021
Q4
$55.3M Sell
200,280
-1,234
-0.6% -$313K 1.47% 11
2021
Q3
$46.5M Sell
201,514
-58,145
-22% -$14.4M 1.34% 29
2021
Q2
$59.6M Buy
259,659
+18,051
+7% +$3.63M 1.73% 3
2021
Q1
$45.1M Buy
241,608
+229,895
+1,963% +$45M 1.36% 36
2020
Q4
$1.98M Sell
11,713
-869
-7% -$130K 0.06% 147
2020
Q3
$1.86M Buy
12,582
+70
+0.6% +$10.8K 0.07% 147
2020
Q2
$2.05M Sell
12,512
-185
-1% -$28.4K 0.08% 136
2020
Q1
$1.76M Sell
12,697
-344
-3% -$47.3K 0.07% 135
2019
Q4
$1.71M Sell
13,041
-840
-6% -$97.4K 0.06% 162
2019
Q3
$1.55M Sell
13,881
-784
-5% -$87.3K 0.05% 177
2019
Q2
$1.63M Sell
14,665
-3,117
-18% -$367K 0.05% 165
2019
Q1
$2.31M Sell
17,782
-250
-1% -$30.4K 0.07% 170
2018
Q4
$2.09M Sell
18,032
-2,060
-10% -$230K 0.07% 164
2018
Q3
$2.16M Sell
20,092
-1,810
-8% -$181K 0.06% 169
2018
Q2
$1.87M Sell
21,902
-770
-3% -$63.2K 0.06% 199
2018
Q1
$1.75M Sell
22,672
-2,620
-10% -$211K 0.06% 197
2017
Q4
$2.14M Buy
25,292
+2,040
+9% +$174K 0.07% 176
2017
Q3
$1.99M Sell
23,252
-30
-0.1% -$2.46K 0.07% 194
2017
Q2
$1.92M Sell
23,282
-430
-2% -$35.1K 0.07% 190
2017
Q1
$1.99M Sell
23,712
-920
-4% -$73.7K 0.07% 183
2016
Q4
$1.81M Buy
24,632
+370
+2% +$27.6K 0.07% 191
2016
Q3
$1.95M Sell
24,262
-13,747
-36% -$1.1M 0.08% 184
2016
Q2
$2.99M Buy
38,009
+140
+0.4% +$10.5K 0.12% 137
2016
Q1
$2.73M Sell
37,869
-32,876
-46% -$2.49M 0.11% 143
2015
Q4
$5.96M Buy
70,745
+4,153
+6% +$345K 0.25% 79
2015
Q3
$5.57M Sell
66,592
-248,594
-79% -$21M 0.24% 78
2015
Q2
$26.3M Sell
315,186
-59,979
-16% -$4.57M 1.08% 32
2015
Q1
$27.3M Buy
375,165
+64,492
+21% +$4.59M 1.16% 33
2014
Q4
$21.4M Buy
310,673
+1,475
+0.5% +$99.6K 1.05% 36
2014
Q3
$20.1M Sell
309,198
-2,869
-0.9% -$182K 1.05% 38
2014
Q2
$19.4M Buy
312,067
+20,117
+7% +$1.2M 1.03% 34
2014
Q1
$17.2M Sell
291,950
-33,677
-10% -$1.88M 1.01% 35
2013
Q4
$16.6M Buy
325,627
+87,048
+36% +$4.36M 1.03% 36
2013
Q3
$12M Buy
238,579
+9,730
+4% +$509K 0.93% 41
2013
Q2
$11.2M Buy
+228,849
New +$12.5M 0.93% 49

Other funds holding LLY

Conning Inc's LLY Position: Q1 2026 in Review

Conning Inc reduced its Eli Lilly (LLY) stake by 6.6% in Q1 2026, selling an estimated $589K and leaving 8,163 shares worth $7.51M. The position accounts for 0.25% of the portfolio, ranked #91.

Conning Inc first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $59.6M in Q2 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Conning Inc held 8,163 shares of Eli Lilly worth $7.51M as of Q1 2026.
  • Conning Inc sold 581 Eli Lilly shares in Q1 2026, an estimated $589K.
  • Eli Lilly made up 0.25% of Conning Inc's portfolio in Q1 2026, its #91 holding.
  • Conning Inc first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Conning Inc's Eli Lilly position peaked at $59.6M in Q2 2021.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.